CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells

被引：0
|
作者：
Jung, In-Young
Kim, Yoon-Young
Yu, Ho-Sung
Kim, Seokjoong
Thon, Jonathan N.
Lee, Jungmin
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3182
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Generation of a conditional analog-sensitive kinase in human cells using CRISPR/Cas9-mediated genome engineering
    Moyer, Tyler C.
    Holland, Andrew J.
    CENTROSOME & CENTRIOLE, 2015, 129 : 19 - 36
  • [32] An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities
    Tal, Yair
    Yaakobi, Shlomo
    Horovitz-Fried, Miryam
    Safyon, Einav
    Rosental, Benyamin
    Porgador, Angel
    Cohen, Cyrille J.
    ONCOTARGET, 2014, 5 (21) : 10949 - 10958
  • [33] Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy
    Zhang, Ang
    Sun, Yao
    Wang, Shenyu
    Du, Jie
    Gao, Xiangyun
    Yuan, Ye
    Zhao, Long
    Yang, Yang
    Xu, Lei
    Lei, Yangyang
    Duan, Lian
    Xu, Chen
    Ma, Lei
    Wang, Jinyu
    Hu, Guoliang
    Chen, Hu
    Wang, Quanjun
    Hu, Liangding
    Zhang, Bin
    CYTOTHERAPY, 2020, 22 (12) : 734 - 743
  • [34] Development and characterization of a CRISPR/Cas9-mediated RAG1 knockout chicken model lacking mature B and T cells
    Lee, Kyung Youn
    Choi, Hyeon Jeong
    Park, Kyung Je
    Woo, Seung Je
    Kim, Young Min
    Han, Jae Yong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancer
    Evtimov, Vera J.
    Nguyen, Nhu-Y N.
    Hammett, Maree, V
    Pupovac, Aleta
    Hudson, Peter J.
    Zhuang, Junli
    Lee, Jae Young
    Kim, Seokjoong
    Trounson, Alan O.
    Boyd, Richard L.
    Shu, Runzhe
    MOLECULAR THERAPY ONCOLOGY, 2025, 33 (02):
  • [36] Improving Efficacy of CAR T Cells through CRISPR/Cas9 Mediated Knockout of TGFBR2
    Welstead, G. Grant
    Vong, Queenie
    Nye, Chris
    Hause, Ron
    Clouser, Chris
    Jones, Jon
    Burleigh, Stephen
    Borges, Christopher M.
    Chin, Melissa
    Marco, Eugenio
    Da Silva, Jen
    Harbinski, Fred
    Giannoukos, Georgia
    Dhanapal, Vidya
    Jiang, Yue
    Salmon, Ruth
    Wilson, Christopher J.
    Myer, Vic
    Bond, Christopher J.
    Sather, Blythe D.
    MOLECULAR THERAPY, 2018, 26 (05) : 61 - 61
  • [37] Generation of FHL2 homozygous knockout lines from human embryonic stem cells by CRISPR/Cas9-mediated ablation
    Chang, Chia-Wei
    Chang, Chih-Chia
    Hsia, Kuo-Chiang
    Tsai, Su-Yi
    STEM CELL RESEARCH, 2018, 27 : 21 - 24
  • [38] CRISPR–Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18
    H W Chu
    C Rios
    C Huang
    A Wesolowska-Andersen
    E G Burchard
    B P O’Connor
    T E Fingerlin
    D Nichols
    S D Reynolds
    M A Seibold
    Gene Therapy, 2015, 22 : 822 - 829
  • [39] Crispr/Cas9-Mediated ASXL1knockout in U937 Human Leukemic Cells Perturbs Myeloid Differentiation
    Wu, Zhijie
    Zhao, Xin
    Banaszak, Lauren G.
    Keyvanfar, Keyvan
    Kajigaya, Sachiko
    Young, Neal S.
    BLOOD, 2016, 128 (22)
  • [40] Generation of immune checkpoint knock-out human antigen-specific T cells via CRISPR/Cas9-mediated genetic engineering
    Zhang, C.
    Peng, Y.
    Hublitz, P.
    Dong, T.
    ANNALS OF ONCOLOGY, 2016, 27
12345